Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.
about
Natriuretic Peptide testing in primary careSerum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese womenAssessment of cardiotoxicity with cardiac biomarkers in cancer patients.Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failureBiomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysisB-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside.N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.NT-proBNP and the diagnosis of exercise-induced myocardial ischaemiaB-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.B-type natriuretic peptides in heart failure: update on clinical applications and limitations.Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.The paradox of low BNP levels in obesity.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance.Role of biomarkers in cardioncology.Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.State of the art of immunoassay methods for B-type natriuretic peptides: An update.A sensor of protein O-glycosylation based on sequential processing in the Golgi apparatus.Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric proteinEffect of plasma protein depletion on BNP-32 recovery.Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure.N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.Regulation of B-type natriuretic peptide synthesis by insulin in obesity in male mice.Analytical and clinical performance of three natriuretic peptide tests in the emergency room.Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk.Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation.Effects of a long-distance run on cardiac markers in healthy athletes.N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome.Accuracy of N-terminal-pro-atrial natriuretic peptide in patients admitted to emergency department.
P2860
Q33572286-9AFF1B5E-DE6D-42A0-B251-02F77453A9EBQ33892494-C1B536B5-879B-46AC-95F3-CC95677AD6CDQ33896047-11B7C461-234D-43DC-BEB3-11B356965094Q34161199-38EADD4D-3C1D-4B5E-A366-E87566E6D69DQ35043024-82B9ED71-61D0-4CFB-9384-774C9482D95CQ35154172-A24A42E4-C1D1-4E69-8F6E-68B166AA976AQ36350919-9A979552-6E19-44BA-AC80-3E4809A7898EQ36442407-19176B86-DE4F-4689-BCBA-743EAF7B2363Q36736728-EEC3E797-C446-4828-8C7C-402EBE7CCC32Q36922698-F4338ABF-6270-4F32-AB2B-8649617AC328Q37425253-7E530B08-D41E-412F-9944-DEFAF78DD30EQ37465179-A89E9A38-94A9-499D-86C1-DC144DB004D5Q37677359-CFC96D44-6FDD-4854-BE3E-6780653C4731Q37734430-BF7D5242-8F97-4DF5-8CC6-E93F050B67E5Q37755062-B3CB8A56-5333-4663-890B-3D187F81D1D3Q37845928-66B07851-7088-4AC1-95CA-B66FB70FA1F2Q37869374-09F42BBE-156E-436A-8C2C-655A526C277CQ37870921-542A7BA2-AFA2-4D1D-8713-287AA7CC25C3Q37873230-06EDDF1C-6786-41E2-BEC0-A0866024BC78Q37922195-9F36B83F-9247-4AE8-9E9A-ACB328A6C698Q37926595-BE84849C-75F2-4A82-9F11-0A0069F37711Q37970489-F7CA0D5F-A840-4230-9F70-9FE395A8E66CQ38303192-80612CD2-F448-45E0-9586-5166403B0C5AQ39540176-4F08DBCC-D739-4D7E-8E63-19C83DF1643AQ39721683-15ACB102-5403-4DB1-81A3-D2A96EBAE22EQ39774019-2FE29DF2-9479-4B73-8879-FFDB1D9A1FE4Q40954684-D50058B5-34CE-4269-B282-ABD09E822BFCQ41001612-A38745F2-C326-4AA6-A8F7-AC9073BA4491Q41810604-E7D5D073-309D-403E-A43D-09CEAE36B321Q42024598-9D792B51-BF59-4635-9E33-52B88C98966AQ42260678-E533FD8B-90C6-47B1-8EE2-C720BB533F5BQ42975785-84087AB2-BBE4-4BEF-8FE5-32A8B4129AE4Q46237102-15F64D10-9C1A-4C09-9ED3-90CE010AEAE4Q47642523-CF1DAEA3-098B-4A02-83DA-0020BB8C1C62Q48176661-9D6055D1-06DF-41D7-9BF2-780577B95BB7Q48370529-C4A907A8-B380-463D-9BCB-CECB3C478A7DQ48402201-31FE39DB-428D-4A93-9D99-D4CD908463D1Q48458807-16D73FB8-7988-4786-9B35-6041CCBDB1EAQ48681415-A74B1D9E-A74E-4104-9DD8-06805D853D07Q48786011-01E7A71D-C550-440C-AD7D-0DB81D131D1A
P2860
Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@ast
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@en
type
label
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@ast
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@en
prefLabel
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@ast
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@en
P1433
P1476
Biochemistry of pro-B-type nat ...... the endocrine heart revisited.
@en
P2093
Jens Peter Goetze
P304
P356
10.1373/CLINCHEM.2004.034272
P407
P577
2004-07-20T00:00:00Z